Syndax received expanded FDA approval for Revuforj, tripling its addressable AML patient population despite a boxed safety ...
Genenta intends to use the net proceeds from the offering for working capital and general corporate purposes. The offering is expected to close on or about October 28, 2025, subject to the ...
AIET cell therapy prolongs survival of cancer patients in Vinmec Hospital, Vietnam, with tech-transfer by GN Corporation & ...
KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia At Global Health Exhibition 2025 ...
Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026PHOENIX, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Creative Medical ...
Looking for gift options for a hair care obsessive? Or for products to add to your own Christmas list? Hair stylist Tom Smith ...